相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。pH-Activatable cell penetrating peptide dimers for potent delivery of anticancer drug to triple-negative breast cancer
So Hee Nam et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Intracellular delivery of immunoglobulin G at nanomolar concentrations with domain Z-fused multimeric α-helical cell penetrating peptides
Seung-Eun Chong et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Challenge to overcome current limitations of cell-penetrating peptides
Gyu Chan Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2021)
Tumor microenvironment responsive drug delivery systems
Qunye He et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Augmented osteogenesis of mesenchymal stem cells using a fragmented Runx2 mixed with cell-penetrating, dimeric a-helical peptide
So Hee Nam et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
α-Helical cell-penetrating peptide-mediated nasal delivery of resveratrol for inhibition of epithelial-to-mesenchymal transition
Yumin Kim et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications
Young Hun Chung et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Improving antibody-based therapies by chemical engineering of antibodies with multimeric cell-penetrating peptides for elevated intracellular delivery
Max Sauter et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
Justine Habault et al.
MOLECULES (2019)
Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines
Sanjay G. Patel et al.
SCIENTIFIC REPORTS (2019)
3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs
Ana S. Nunes et al.
BIOTECHNOLOGY AND BIOENGINEERING (2019)
Multimeric Amphipathic -Helical Sequences for Rapid and Efficient Intracellular Protein Transport at Nanomolar Concentrations
Jae Hoon Oh et al.
ADVANCED SCIENCE (2018)
Oligomer Formation Propensities of Dimeric Bundle Peptides Correlate with Cell Penetration Abilities
Soonsil Hyun et al.
ACS CENTRAL SCIENCE (2018)
Enhanced nanoparticle delivery exploiting tumour-responsive formulations
Lindsey A. Bennie et al.
CANCER NANOTECHNOLOGY (2018)
Affibody molecules as engineered protein drugs
Fredrik Y. Frejd et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Dual Receptor Recognizing Cell Penetrating Peptide for Selective Targeting, Efficient Intratumoral Diffusion and Synthesized Anti-Glioma Therapy
Yayuan Liu et al.
THERANOSTICS (2016)
3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained
Michele Zanoni et al.
SCIENTIFIC REPORTS (2016)
Protease-Activable Cell-Penetrating Peptide-Protoporphyrin Conjugate for Targeted Photodynamic Therapy in Vivo
Shi-Ying Li et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
15 years of ATTEMPTS: Amacromolecular drug delivery systembased on the CPP-mediated intracellular drug delivery and antibody targeting
Junxiao Ye et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Nanoparticle uptake: The phagocyte problem
Heather Herd Gustafson et al.
NANO TODAY (2015)
Cell-penetrating peptides: strategies for anticancer treatment
Drazen Raucher et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Cell-Penetrating, Dimeric α-Helical Peptides: Nanomolar Inhibitors of HIV-1 Transcription
Sangmok Jang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Heparan sulfate in the regulation of neural differentiation and glioma development
Anqi Xiong et al.
FEBS JOURNAL (2014)
Cell penetration: scope and limitations by the application of cell-penetrating peptides
Siegmund Reissmann
JOURNAL OF PEPTIDE SCIENCE (2014)
Heparan sulfate proteoglycan as a cell-surface endocytosis receptor
Helena C. Christianson et al.
MATRIX BIOLOGY (2014)
Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate
Srinath Govindarajan et al.
BIOMATERIALS (2012)
Biodistribution and Clearance of Small Molecule Hapten Chelates for Pretargeted Radioimmunotherapy
Kelly Davis Orcutt et al.
MOLECULAR IMAGING AND BIOLOGY (2011)
Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications
J. Lofblom et al.
FEBS LETTERS (2010)
Structural basis for high-affinity HER2 receptor binding by an engineered protein
Charles Eigenbrot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Building Cell Selectivity into CPP-Mediated Strategies
Irene Martin et al.
PHARMACEUTICALS (2010)
Imaging of HER-2 Overexpression in Tumors for Guiding Therapy
V. Tolmachev
CURRENT PHARMACEUTICAL DESIGN (2008)
Theoretic criteria for antibody penetration into solid tumors and micrometastases
Greg M. Thurber et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Tumor Imaging using a picomolar affinity HER2 binding affibody molecule
A Orlova et al.
CANCER RESEARCH (2006)
Impact of polymorphisms in the genes encoding xylosyltransferase I and a homologue in type 1 diabetic patients with and without nephropathy
S Schön et al.
KIDNEY INTERNATIONAL (2005)
Characterisation of cell-penetrating peptide-mediated peptide delivery
SW Jones et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
分享论文
